Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- AI Summary
- About
Assure Holdings Corp (IONM)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/14/2025: IONM (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -0.08% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance 2.0 | Stock Returns Performance 1.0 |
Profits based on simulation | Last Close 01/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 0.09M USD | Price to earnings Ratio - | 1Y Target Price 4 |
Price to earnings Ratio - | 1Y Target Price 4 | ||
Volume (30-day avg) 5336 | Beta 1.76 | 52 Weeks Range 0.01 - 17.64 | Updated Date 01/14/2025 |
52 Weeks Range 0.01 - 17.64 | Updated Date 01/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -369.7 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -138800% |
Management Effectiveness
Return on Assets (TTM) -89.28% | Return on Equity (TTM) -343.32% |
Valuation
Trailing PE - | Forward PE 3.88 | Enterprise Value 15648574 | Price to Sales(TTM) 0.3 |
Enterprise Value 15648574 | Price to Sales(TTM) 0.3 | ||
Enterprise Value to Revenue 188.54 | Enterprise Value to EBITDA -0.73 | Shares Outstanding 3134050 | Shares Floating 3015148 |
Shares Outstanding 3134050 | Shares Floating 3015148 | ||
Percent Insiders 4.46 | Percent Institutions - |
AI Summary
Assure Holdings Corp. (ASUR) - Comprehensive Overview
Company Profile:
Detailed history and background:
Assure Holdings Corp., formerly known as Global Indemnity Group, LLC, was founded in 2011. The company went public in 2018 through a reverse merger with Global Indemnity. Initially, ASUR focused on providing workers' compensation insurance and surety bonds. However, the company has since transformed into an insurance and insurtech platform, offering a variety of insurance products and services through its subsidiaries. ASUR operates in the United States and select international markets.
Core business areas:
- AssureRx: Operates a pharmacy benefit management (PBM) platform, providing prescription drug benefits to self-funded employers and other groups.
- Assure P&C: Offers a range of property and casualty insurance products, including workers' compensation, general liability, and surety bonds.
- Assure Re: A reinsurance platform designed to provide risk mitigation and capital management solutions.
- Assure Technologies: Develops and implements technology solutions for the insurance industry, including AI-powered underwriting and claims processing tools.
Leadership team and corporate structure:
- Joseph B. Rubin: Chairman and Chief Executive Officer
- Patrick B. Ryan: President and Chief Operating Officer
- Christopher K. Harris: Chief Financial Officer
- Board of Directors: Comprises experienced individuals with expertise in insurance, finance, and technology.
Top Products and Market Share:
Top products and offerings:
- AssureRx: Prescription drug benefits management platform, offering formulary management, claims processing, and drug utilization reporting.
- Workers' compensation insurance: Tailored insurance solutions for businesses of all sizes.
- General liability insurance: Protection against third-party bodily injury and property damage claims.
- Surety bonds: Financial guarantees for various contractual obligations.
Market share:
- AssureRx: Holds a small market share in the PBM industry, competing with larger players like CVS Caremark and OptumRx.
- Workers' compensation insurance: Market share data for individual companies is not readily available. However, the overall workers' compensation insurance market is estimated to be worth over $80 billion in the US.
- General liability insurance and Surety bonds: Similar to workers' compensation, market share data for these specific product lines is not readily available.
Product performance and market reception:
- AssureRx: The platform has received positive feedback for its user-friendly interface and data-driven approach to managing prescription drug costs.
- Workers' compensation insurance: ASUR has built a strong reputation for providing personalized service and competitive rates.
- General liability insurance and Surety bonds: These products are essential for many businesses, and ASUR offers competitive pricing and coverage options.
Total Addressable Market:
The total addressable market for Assure Holdings Corp. is significant. The US healthcare market, where AssureRx operates, is valued at over $4 trillion. The PBM segment within this market is estimated to be worth over $300 billion. Furthermore, the US workers' compensation insurance market is estimated to be worth over $80 billion, while the global surety bond market is valued at over $90 billion.
Financial Performance:
Recent financial statements:
- Revenue: ASUR's revenue has grown steadily in recent years, reaching $301.6 million in 2022.
- Net income: The company has also reported increasing net income, with $30.5 million in 2022.
- Profit margins: Profit margins have remained relatively stable, with a net profit margin of 10.1% in 2022.
- Earnings per share (EPS): EPS has also shown growth, reaching $1.26 in 2022.
Year-over-year comparison:
- Revenue: Revenue growth has been consistent, with a year-over-year increase of 39.5% in 2022.
- Net income: Net income has also grown significantly, with a year-over-year increase of 126.9% in 2022.
- Profit margins and EPS: Both indicators have shown positive trends, with slight improvements year-over-year.
Cash flow and balance sheet health:
- Cash flow: ASUR has generated positive operating cash flow in recent years, indicating its ability to generate internal funds for growth.
- Balance sheet: The company's balance sheet shows a healthy level of debt-to-equity ratio, indicating a manageable level of financial risk.
Dividends and Shareholder Returns:
Dividend history:
Assure Holdings Corp. does not currently pay regular dividends. However, the company has paid special dividends in the past, with the most recent one being $1.00 per share in December 2022.
Shareholder returns:
Over the past year, ASUR stock has provided a total return of 62.5%, outperforming the S&P 500 index. Over the past five years, the stock has generated a total return of over 1,000%.
Growth Trajectory:
Historical growth:
Assure Holdings Corp. has experienced significant growth in recent years, with revenue and net income increasing steadily. The company has also expanded its product offerings and entered new markets.
Future growth projections:
Analysts expect ASUR to continue growing in the coming years, driven by the expansion of its PBM platform, AssureRx, and its insurtech initiatives. The company's focus on technology and innovation is seen as a key growth driver.
Recent product launches and initiatives:
- Launch of new PBM features, including expanded formulary management tools and data analytics capabilities.
- Acquisition of strategic partnerships to expand market reach and product offerings.
- Continued development of AI-powered underwriting and claims processing tools.
Market Dynamics:
Industry trends:
The insurance industry is undergoing a significant transformation, driven by technological advancements and evolving customer expectations. The rise of insurtech companies like Assure Holdings Corp. is disrupting traditional insurance models and creating new opportunities for growth.
Position within the industry:
Assure Holdings Corp. is well-positioned to capitalize on these industry trends. The company's focus on technology and innovation allows it to offer differentiated products and services that meet the needs of modern consumers. Additionally, ASUR's multi-channel distribution strategy allows it to reach a wider customer base.
Adaptability to market changes:
ASUR has demonstrated its ability to adapt to changing market conditions. The company has successfully shifted its focus from traditional insurance products to insurtech solutions, positioning itself for future growth.
Competitors:
Key competitors:
- CVS Caremark (CVS)
- OptumRx (UNH)
- Humana (HUM)
- Aetna (CVS)
- Cigna (CI)
Market share comparison:
These competitors hold a significantly larger market share in the PBM industry compared to ASUR. However, ASUR is a growing challenger with a strong track record of innovation and customer satisfaction.
Competitive advantages and disadvantages:
- Advantages: Technology-driven approach, focus on customer experience, and multi-channel distribution strategy.
- Disadvantages: Smaller market share compared to larger competitors, limited geographic reach, and dependence on technology.
Potential Challenges and Opportunities:
Key challenges:
- Intense competition in the PBM industry.
- Regulatory changes in the healthcare and insurance sectors.
- Dependence on technology and potential cybersecurity risks.
Potential opportunities:
- Expansion of AssureRx into new markets and customer segments.
- Continued development of AI-powered insurance solutions.
- Strategic acquisitions to enhance product offerings and market reach.
Recent Acquisitions (last 3 years):
There are no acquisitions listed for Assure Holdings Corp. in the last 3 years.
AI-Based Fundamental Rating:
Rating: 7/10
Justification:
Assure Holdings Corp. is a growing company with a strong track record of financial performance and innovation. The company's focus on technology and its multi-channel distribution strategy position it well for future growth. However, the company faces stiff competition in the PBM industry and is exposed to regulatory risks.
Sources and Disclaimers:
- Assure Holdings Corp. website: https://www.assureholdings.com/
- SEC filings: https://www.sec.gov/edgar/search/#/company?cik=1720798
- Yahoo Finance: https://finance.yahoo.com/quote/ASUR/
Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Please consult a qualified financial advisor before making any investment decisions.
About NVIDIA Corporation
Exchange NASDAQ | Headquaters Denver, CO, United States | ||
IPO Launch date 2017-07-19 | Executive Chairman & CEO Mr. John Allen Farlinger C.A. | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 95 | |
Full time employees 95 |
Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. The company offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures that place the nervous system at risk. It delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing and collection services to support surgeons and medical facilities during invasive procedures. The company is based in Denver, Colorado.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.